Lorenz Mayr

Lorenz has over 30 years’ experience in biopharma research, development and commercialization. Most recently, he was Chief Technology Officer at GE Healthcare Life Sciences, where he was responsible for research investments, talent development and company growth strategy across all business areas. His former positions include Vice President & Global Head at AstraZeneca, where he oversaw the generation of biological reagents and assay development activities across all therapeutic areas, and Executive Director at Novartis.

Lorenz is a biochemistry lecturer at the Martin Luther University Halle-Wittenberg and has published over 60 peer-reviewed papers.